Menu
Other

Will the WHO declare a hantavirus pandemic in 2026?

Resolution: Updated:
4%

market consensus

chance the market gives this event โ€” not your chance of being right

Yes โ€” The event happens
4%
No โ€” The event does not happen
96%

In short

The market treats this as very unlikely. The core reason is biological rather than political: hantaviruses spread from rodents to people, not routinely from person to person, and the World Health Organization has never applied the word "pandemic" to them in more than three decades of surveillance. Only documented, sustained human-to-human transmission of a hantavirus across multiple countries โ€” followed by the WHO explicitly using the word "pandemic" rather than the narrower emergency language it normally reaches for โ€” would move this materially.

How the contract works

A contract on this question settles at $1 if the outcome happens and at nothing if it does not. The price is simply what buyers and sellers currently agree the chance is, expressed as cents on that dollar: a contract trading at 0.30 would mean the market thinks the event happens about three times in ten. Here, settlement turns on whether the World Health Organization explicitly uses the word "pandemic" for hantavirus, HPS, HFRS or a hantavirus outbreak in an official public communication on or before 31 December 2026, 11:59 PM ET. A Public Health Emergency of International Concern on its own does not settle it Yes unless the word "pandemic" is also used. A position does not have to be held to the settlement date โ€” it can usually be sold beforehand at whatever the price is at that moment.
What the market thinks happens
$100
Yes4%

The event happens

Costs now
$0.04
If you put in $100
$2,500
No96%

The event does not happen

Costs now
$0.96
If you put in $100
$104
0%25%50%75%100%14:2919:3500:4205:4910:5516:02
ConsensusPolymarket

How the price has moved

There is almost nothing to narrate, and that is the finding. The recorded series opened on 29 July 2026 and has not moved since: across 67 logged observations the range is a single level, with the No side of the contract at 97% throughout and the Yes side correspondingly near 3%. No high, no low, no reaction to news. Against roughly $17.2 million of cumulative volume, that flatness is not thin-market noise โ€” it is a large body of participants agreeing that the question is close to settled and that outbreak coverage in the US Southwest does not change the answer. The market is not waiting for evidence; it is waiting for the calendar.

Context

Hantaviruses are a family of rodent-borne viruses found on every inhabited continent. In the Americas they cause Hantavirus Pulmonary Syndrome (HPS), a respiratory illness with a high case fatality rate; across Eurasia, related strains cause Haemorrhagic Fever with Renal Syndrome (HFRS), which is far more common but usually less lethal. Human infection almost always comes from inhaling aerosolised droppings or urine of infected rodents, typically deer mice in the western United States, in enclosed spaces such as sheds, cabins and barns. The disease entered American public consciousness during the 1993 Four Corners outbreak, when a cluster of deaths in the Southwest led to the identification of Sin Nombre virus. It returns to the news periodically: a 2012 cluster among visitors to Yosemite National Park, and in March 2025 the confirmation by New Mexico health officials that Betsy Arakawa, the wife of the actor Gene Hackman, had died of hantavirus pulmonary syndrome. Annual United States case counts run in the dozens, not the thousands. What makes this a market rather than a certainty is post-COVID sensitivity to WHO language. Since 2020, readers and traders track the organisation's terminology closely, and the 2024 amendments to the International Health Regulations added a formal "pandemic emergency" category above a Public Health Emergency of International Concern. That gives the WHO a vocabulary it did not previously have. The question is whether hantavirus is the pathogen it would ever be used on.

Analysis

The consensus across venues sits at 3%, and all recorded trading is on Polymarket, so there is no cross-venue spread to interpret โ€” no gap between two settlement sources, no arbitrage story. What there is instead is size: roughly $17.2 million in cumulative volume on a question about a virus that infects a few dozen Americans a year. That volume is the interesting number. It tells you the market has been priced by a lot of participants rather than a handful, which is why the level has not drifted. The recorded price history is short and completely flat. Sixty-seven observations have been logged since the series began on 29 July 2026, and the range across all of them is a single level โ€” the complementary side of the contract has sat at 97% throughout, which is the same statement as the Yes side sitting near 3%. A flat line with no high and no low is a market that considers the question effectively answered and is waiting only for the calendar to run out. It is not a market digesting news. The reason is mechanical. To be a pandemic, a pathogen needs efficient and sustained transmission between humans across regions. Hantaviruses almost entirely lack it. The one documented exception is Andes virus in Argentina and Chile, where person-to-person spread has been recorded in family and healthcare clusters โ€” but those chains have been short and geographically contained, never continental. Every other strain, including Sin Nombre in the United States, requires a rodent in the chain. A large rodent population year would raise case counts in the Southwest; it would not create a pandemic. Then there is WHO behaviour. The organisation is conservative with the word. It applied it to H1N1 in 2009 and to COVID-19 in March 2020, and it has conspicuously declined to apply it in cases where public pressure existed โ€” mpox received a Public Health Emergency of International Concern in 2022 and again in August 2024 without being called a pandemic. The settlement rules here are drafted precisely around that distinction: emergency language alone does not count. So a Yes needs two independent low-probability events in the same five months โ€” a biologically unprecedented transmission pattern, and a rhetorical choice the WHO has avoided even for diseases spreading between humans in dozens of countries. With five months left to 31 December 2026, the practical path to Yes narrows further. Even a genuinely alarming hantavirus cluster would first move through national health ministries, then a WHO risk assessment, then possibly an emergency committee โ€” a sequence that historically takes weeks to months before any formal designation. The remaining time is a constraint in itself, and it is one reason a low price becomes lower as the year runs down rather than staying static.

What moves the probability

  • Absence of human-to-human spread

    Hantaviruses are contracted from rodents, not from other people, with the narrow exception of Andes virus clusters in Argentina and Chile. Without sustained person-to-person chains, the epidemiological definition of a pandemic cannot be met. This is the single largest force holding the probability down, and nothing short of a documented, multi-country transmission chain would weaken it.

  • WHO's conservative vocabulary

    The WHO declined to call mpox a pandemic despite emergency declarations in 2022 and 2024. The 2024 International Health Regulations amendments created a "pandemic emergency" tier, but it has not been invoked for a rodent-borne disease and the settlement rules explicitly exclude emergency language that stops short of the word "pandemic". This pushes the probability down and explains why the market barely reacts to outbreak headlines.

  • Seasonal case clusters in the US Southwest

    Wet years increase deer mouse populations and, with a lag, HPS case counts in New Mexico, Arizona, Colorado and Utah. A cluster of deaths would generate heavy national coverage and could produce brief upward pressure on the price. Historically such clusters have involved single-digit to low double-digit case numbers and no international spread, so the effect is on attention rather than on the underlying probability.

  • Time remaining to 31 December 2026

    Any WHO designation follows a sequence of national reporting, risk assessment and committee review that takes weeks at minimum. With roughly five months to settlement, even a serious new outbreak beginning now would struggle to reach a formal pandemic declaration inside the window. This driver pushes the probability progressively lower as the year closes.

  • Novel strain or laboratory finding

    The realistic upside scenario is the emergence of a hantavirus strain with altered transmissibility, or genomic evidence of adaptation to human-to-human spread. Such a finding, published or announced by a national agency, would be the trigger that moves this market meaningfully rather than cosmetically. The market prices this as remote.

  • Volume and price stability

    Cumulative volume across venues is about $17.2 million with the recorded price series showing no movement at all across 67 observations. Deep, static markets are the hardest to shift, because a move requires new information rather than a change in sentiment. This reinforces the current level rather than pushing it in either direction.

The case for

  • A hantavirus strain would need to demonstrate efficient human-to-human transmission, with genomic or epidemiological evidence of chains extending beyond family and healthcare contacts.
  • Cases would need to appear in multiple countries and regions simultaneously, which for a rodent-borne virus means either a shared reservoir expansion or a transmission route not previously documented.
  • The WHO would then need to escalate past a Public Health Emergency of International Concern and use the specific word "pandemic" in an official statement, report, briefing or publication before 11:59 PM ET on 31 December 2026.
  • All three steps would have to complete inside roughly five months, compressing a process that took the WHO from late January to 11 March 2020 in the case of COVID-19.

The case against

  • Hantaviruses have been under global surveillance since 1993 and have never produced sustained human-to-human transmission outside short Andes virus clusters in South America.
  • United States case counts run in the dozens annually and are driven by rodent exposure in enclosed spaces, a pattern that produces geographically scattered cases rather than epidemic curves.
  • The WHO withheld the word "pandemic" from mpox even while declaring it a Public Health Emergency of International Concern twice, and the settlement rules here treat that distinction as decisive.
  • With the settlement date on 31 December 2026, the remaining window is too short to accommodate the full escalation sequence even if an unprecedented outbreak began immediately.

Trade this contract

Venues (1)

Venues (1)

Resolution rules

Determined by
Official World Health Organization communications (statements, reports, press briefings, publications), supported by a consensus of credible reporting
Resolution date

The question resolves Yes only if the World Health Organization explicitly describes hantavirus, Hantavirus Pulmonary Syndrome, Haemorrhagic Fever with Renal Syndrome, or a hantavirus-related outbreak as a "pandemic" in an official public communication โ€” a statement, report, press briefing or publication โ€” on or before 31 December 2026, 11:59 PM ET. Declaring a Public Health Emergency of International Concern, or invoking the "pandemic emergency" category under the International Health Regulations without using the word "pandemic" for hantavirus, does not qualify. Where wording is contested, resolution relies on a consensus of credible reporting on what the WHO said. Only one venue currently trades this question, so there is no divergence between settlement sources to account for. Any other outcome settles No.

Calculation methodology โ†’

Local context

For readers in the United States, this is a domestic disease story before it is an international one. Hantavirus pulmonary syndrome is concentrated in the Four Corners states and the wider West, it has a high case fatality rate, and it resurfaces in national coverage whenever there is a cluster or a high-profile death โ€” as in March 2025, when New Mexico officials attributed Betsy Arakawa's death to it. The gap between how frightening the disease is individually and how limited it is epidemiologically is exactly what this market prices. For readers elsewhere, the value is in the mechanics of WHO language. Since March 2020, terminology from Geneva has moved currencies, travel rules and equity indices, and the 2024 International Health Regulations amendments added a new "pandemic emergency" tier that has yet to be used. Watching how a market prices the chance of the WHO applying its strongest word to a pathogen that cannot readily spread between humans is a useful calibration for the next time a genuine airborne threat appears โ€” and a reminder that in the UK, Canada, Australia and India, national response plans are triggered by WHO designations rather than by case counts alone.

What to watch

Three things would matter between now and 31 December 2026. First, the WHO's Disease Outbreak News feed and its regional office bulletins for the Americas and the Western Pacific โ€” that is where any hantavirus cluster would be logged first, and the language used there is the leading indicator for anything stronger. Second, US Centers for Disease Control and Prevention case reporting and state health department notices from New Mexico, Arizona, Colorado and California, which historically drive the seasonal spikes in HPS coverage between spring and late summer. Third, any convening of a WHO emergency committee under the International Health Regulations for a hantavirus, which would be the first formal step on the escalation ladder; note that even a Public Health Emergency of International Concern out of such a committee would not settle this question Yes on its own. Absent any of those, the probability drifts down mechanically as the window closes.

Common questions

What exactly settles this question, and when?
Official World Health Organization communications โ€” statements, reports, press briefings or publications โ€” supported by a consensus of credible reporting. The WHO must explicitly describe hantavirus, HPS, HFRS or a hantavirus outbreak as a "pandemic" on or before 31 December 2026, 11:59 PM ET. If that has not happened by then, the question settles No.
Would a Public Health Emergency of International Concern be enough?
No. The rules are explicit that a PHEIC alone does not qualify. The WHO would have to use the word "pandemic" as well. This distinction is not academic: mpox received a PHEIC in 2022 and again in August 2024 and was never called a pandemic by the WHO.
What does a low price on this contract actually mean?
A contract settles at $1 if the event happens and at nothing if it does not, so the price in cents is the market's estimate of the chance. A price of 0.30 would mean the market sees roughly a three-in-ten chance. A price in the low single digits means participants think the outcome is possible in principle but far outside the expected path.
Can hantavirus spread between people at all?
Almost never. The overwhelming majority of infections come from inhaling aerosolised rodent droppings or urine. The documented exception is Andes virus in Argentina and Chile, where person-to-person transmission has been recorded in family and healthcare settings, but those chains have been short and contained. That is why hantavirus is treated as a serious individual risk rather than a pandemic risk.
What happens if the WHO uses ambiguous language, such as "pandemic potential"?
The rules require the WHO to describe the outbreak as a pandemic, not to speculate about potential. Phrases such as "pandemic potential" or "pandemic preparedness" describe a risk category, not a declaration, and would not on their own settle the question Yes. Ambiguous cases would fall back on a consensus of credible reporting on whether the WHO in fact called it a pandemic.
Why is there so much trading volume on such a one-sided question?
Cumulative volume across venues is about $17.2 million, all of it on Polymarket. High-probability outcomes attract volume precisely because they look near-certain: participants take the likely side for a small return, and others take the unlikely side cheaply against a tail event. The result is a deep market whose price barely moves, which is what the recorded history shows.

Related events